What is the current stock price of ESSA Pharma Inc. (EPIX)?

As of the latest market data, ESSA Pharma Inc. (EPIX) is trading at $0.20. The stock has seen a loss of -1.85% today.

Does ESSA Pharma Inc. (EPIX) pay a dividend?

Based on current data, ESSA Pharma Inc. does not have a confirmed active dividend policy.

What is the market cap of ESSA Pharma Inc.?

The current market capitalization of ESSA Pharma Inc. (EPIX) is approximately unavailable.

EPIX

ESSA Pharma Inc.·Healthcare

0.20

1.854%(−0.00)

Close Price

0.20

0.646%(−0.00)

After Hours

Last Updated: — ET

52W L: $0.1852W H: $6.45

Company Profile

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2015-03-13

Beta

1.53

Websitewww.essapharma.com↗